SynthesisBMC psychiatry2026
TNF-α levels in first-episode, drug-naïve patients with major depressive disorder: a case-control study and meta-analysis.
Synthesis in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- TNF-dependent regulation of synaptic plasticity and neuronal activity: implications for psychiatric disorders.Molecular psychiatry · 2026Review
- The Mental Health-Acute Coronary Syndrome Continuum: Bidirectional Pathophysiological Links and Clinical Implications.Medical sciences (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMajor Depressive Disorder (MDD) is a common psychiatric condition with a multifactorial etiology that includes inflammatory mechanisms. Tumor Necrosis Factor-α (TNF-α), a pro-inflammatory cytokine, regulates several cellular functions in health and has been associated with reduced neuronal survival and increased inflammation in cortical areas related to reward processing, motivation, and decision-making in MDD. Although TNF-α has been studied in MDD, its precise role remains unclear, highlighting the need for further investigation. We therefore conducted a case-control study and a meta-analysis to better characterize peripheral blood TNF-α levels in first-episode, drug-naïve MDD patients compared with healthy controls.
methodsIn the case-control study, plasma TNF-α levels were measured in first-episode, drug-naïve patients with major depressive disorder (MDD) and healthy controls (HCs) matched on age, and sex, using high-sensitivity enzyme-linked immunosorbent assays (ELISAs). For the meta-analysis, we selected relevant case-control studies from systematic searches of PubMed, Embase, PsycINFO, and Web of Science. A random effects model was used to calculate combined standardized mean differences (SMD) and ratio of means (RoM) for result verification.
resultsA total of 63 MDD patients and 63 matched HCs were included in the case-control analysis. Plasma TNF-α levels were significantly higher in MDD patients than in HCs (z = -2.12, p < 0.05). For the meta-analysis, 16 studies comprising 866 patients and 759 controls were included. Pooled results demonstrated significantly higher TNF-α levels in MDD patients compared with HCs (SMD: Hedges’ g = 0.65, 95% CI: 0.28 to 1.01, p < 0.001). The RoM indicated a 30% higher mean concentration in patients (RoM = 1.30, 95% CI: 1.20 to 1.42, p < 0.001). However, substantial cross-study heterogeneity was observed (SMD: I² = 91.2%, p < 0.001; RoM: I² = 95.5%, p < 0.001).
conclusionsThe results of both the case-control and meta-analysis portions of our study suggest that TNF-α levels are higher in first-episode, drug-naïve MDD patients than in healthy individuals. These findings imply that TNF-α plays an important role in the pathophysiology of MDD. Future work should examine sources of heterogeneity across studies on inflammatory factors in depression, and assess potential therapeutic targets associated with TNF-α. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.